FREE SHIPPING ON ORDERS OVER $150

glp-1 agonist therapy Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Gastrointestinal effect and adverse effects

$24.72

Quantity
- +
Description

In the obesity group, 979 patients were studied

glp-1 agonist therapy Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Gastrointestinal effect and adverse effects

10.1155/2019/1968785 59 ZelnikerT

glp-1 agonist therapy Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Gastrointestinal effect and adverse effects

Nagao-Kitamoto, H

glp-1 agonist therapy Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Gastrointestinal effect and adverse effects

Identification and importance of brown adipose tissue in adult humans

glp-1 agonist therapy Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Gastrointestinal effect and adverse effects

Effects of Liraglutide on heart rate and heart rate variability: a randomized, double-blind, placebo-controlled crossover study

glp-1 agonist therapy Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Gastrointestinal effect and adverse effects

& Kahn, B

glp-1 agonist therapy Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Gastrointestinal effect and adverse effects

You may also like

recommand products